To determine the effects of chronic coronary 
Introduction
In coronary artery disease, focal narrowing of the main coronary arteries by atherosclerosis is the most frequent pathologic process responsible for the reduction in coronary blood flow to the myocardium. Although the severity of the atherosclerotic involvement of the coronary circulation seems to correlate with the impairment ofblood supply to the tissue (1) , in a large number of patients there is no correlation between the clinical manifestations of ischemia and the angiographic evaluation of the magnitude ofconstriction ofthe epicardial arteries (2) . This discrepancy is further emphasized by anatomical findings which indicate that in congestive ischemic heart disease (3, 4) only relatively small amounts of myocardium are lost and replaced by fibrotic tissue, providing no basis for the ultimate events of irreversible congestive heart failure and death (3, 4) . Consistent with these observations, acute (5) and subacute (6) nonocclusive coronary artery stenoses in rats have been found to be associated with severe alterations in cardiac function, and sites of reparative fibrosis and myocytolytic necrosis primarily affecting the subendocardium and midmyocardium of the left ventricular wall (5, 6) . However, the relatively moderate extent of myocyte necrosis and replacement scarring cannot fully account for the depression in ventricular hemodynamics, because similar alterations in cardiac function are commonly seen after total occlusion of the coronary artery and infarcts affecting nearly 50% of the wall acutely (7) and chronically (8) in rats. Although ischemia may be implemented as the prevailing mechanism of myocardial dysfunction (9) , coronary narrowing, involving a reduction in luminal diameter up to 62%, has no effect on resting coronary blood flow (5, 6) to support the hypothesis ofa decreased oxygen availability to the tissue and ventricular failure. In view of these contrasting observations, the possibility may be advanced that nonocclusive coronary constriction may result in a depressed force-generating capacity of the myocardium mediated by abnormalities in the adrenergic mechanisms supporting myocardial contractility. Because the inotropic state of heart muscle is mostly controlled by the f3-adrenoreceptor adenylate cyclase complex (10) , a decrease in f3-adrenoreceptor density and/or attenuation in the activation ofthe regulatory protein coupling these receptors with adenylate cyclase may be implicated in the depression of mechanical pump performance after coronary artery narrowing. The chronic effects of coronary constriction have been investigated here because oftheir relevance to the human disease.
Methods
Experiments were carried out in male Sprague-Dawley rats at 3 mo of age weighing -250-275 g (Charles River Breeding Laboratories, North Wilmington, MA). Coronary artery narrowing was performed in 27 animals. Eight animals in this group died within 2-3 wk after coronary constriction mostly because of pulmonary edema. 22 sham-operated rats served as controls. All animals were killed 5 mo after surgery.
Coronary artery narrowing. Under ether anesthesia, thoracotomy via the third left intercostal space was performed, the atrial appendage elevated, the left coronary artery located, and a suture positioned around the vessel 1-2 mm from its origin. Subsequently, a probe 275 /im in diameter was held in contact with the wall of the exposed coronary artery. The entire vessel and the probe were ligated and the probe quickly removed (5, 6) . The chest was closed and the animals allowed to recover. Sham-operated control rats were treated similarly except that the ligature around the coronary artery was not tied.
Functional measurements. Just before being killed, animals were anesthetized with chloral hydrate (300 mg/kg body weight, ip), and the tip pressure transducer catheter (model PR 249; Millar Instruments, Houston, TX) connected to an electrostatic chart recorder (model ES 2000; Gould Inc., Cleveland, OH). After monitoring arterial blood pressure the catheter was advanced into the left ventricle for the evaluation of left ventricular pressures and dP/dt. Thus, measurements were made ofarterial and ventricular pressures, and dP/dt in the closed chest preparation. These events were monitored and inscribed on recording paper for subsequent analysis.
Measurement ofthe degree ofcoronary artery constriction. At death (see below), in each heart, the initial 2-3-mm segment ofthe left coronary artery was dissected free to localize the level ofcoronary constriction. The vessel was then cut transversely to expose the lumen of the coronary artery at the region of the ligature. The luminal diameter of the proximal portion of the vessel adjacent to the narrowed site and at the constricted region were measured with a dissecting microscope having an incorporated ocular reticle. The degree ofconstriction was evaluated by comparing the vessel diameter above the stenosis with the diameter at the level of the stenosis (5, 6).
fl-Adrenoreceptors
Membranepreparation. After the measurement ofphysiologic parameters, 15 rats from the coronary-constricted (CC)' group and 15 rats from the sham-operated group were killed by decapitation. The hearts were rapidly excised and placed in ice-cold saline. The aorta and great vessels were discarded, and the left and right ventricles were separated and weighed. (12) . Molecular weight markers were also applied to the gel and electrophoresis was terminated when the dye front left the bottom of the gel. The gels were stained with 50% methanol, 10% glacial acetic acid, and 0.20% coomassie blue, and then disdained with 10% methanol and 10% glacial acetic acid. The gels were dried and subjected to autoradiography using Kodak XAR5 film (Eastman Kodak Co., Rochester, NY) at -70°C. The incorporation of radioactive label was quantitated directly from the gel (13) by a computer-assisted radioanalytic imaging system (AMBIS Systems, Inc., San Diego, CA). The molar amount of incorporated label was calculated from the total counts contained in the labeled bands and the specific activity of the [32P]NAD.
Alkaline phosphatase activity. A spectrophotometric assay (14, 15) was employed to measure alkaline phosphatase activity in myocardial membranes from coronary-constricted and control hearts. The determinations were performed on aliquots of pooled membrane vesicles used in receptor and adenylate cyclase assays. Values are expressed as units of alkaline phosphatase activity per microgram of membrane protein.
Statistical analysis. Values are reported as means±SE. Comparisons between values in controls and coronary-constricted rats were performed using a two-tailed, unpaired Student's t test. Comparisons between the left and right ventricles within each group were done utilizing a paired Student's t test. P values < 0.05 were considered to be significant. Because at times samples were pooled, n values for each determination are listed in the text or the legend of each figure.
Results
Coronary constriction and ventricular hemodynamics. The experimental procedures used resulted in a 44+2.4% reduction in the luminal diameter of the left coronary artery near its origin. This change in linear dimension corresponded to a 61% decrease in mean cross-sectional area of the coronary lumen. Sham operation had no effect on coronary artery luminal diameter in control rats. 5 mo after coronary artery narrowing, systolic, diastolic, and mean arterial blood pressures were decreased by 7, 6, and 4%, respectively. Heart rate was increased by 4%. However, all these differences were found not to be statistically significant (data not shown). In contrast, left ventricular minimal diastolic pressure increased by 6.9-fold, from 27±1.40 mm Hg (Fig. 1 A) . Whereas peak systolic ventricular pressure did not change in coronary-constricted rats (Fig. 1 B) , peak positive dP/dt was reduced by 29%. Moreover, negative dP/dt was also decreased by 15%. However, there were no signs ofliver congestion and ascites to indicate global cardiac failure.
In summary, impairment of left ventricular function was present 5 mo after moderate degrees of coronary artery narrowing.
Gross cardiac characteristics. Fig. 2 illustrates the changes in the weight ofthe heart and its major subdivisions 5 mo after coronary artery constriction. Overall heart weight was found to be increased by 16% in experimental animals (control: 1,204±15 mg; CC: 1,391±49) as a result of a 12% augmentation in left ventricular weight (control: 935±17 mg; CC: 1,045±31 mg) and a 29% expansion in the weight of the right ventricular free wall (control: 269±2.3 mg; CC: 346±18 mg). These changes were all statistically significant.
Because body weight did not differ in control (499±3 g) and experimental (487±9 g) animals, the ratios ofheart weight/, left ventricular weight/, and right ventricular weight/body weight were increased in coronary-constricted rats. In particular, the augmentations in the left and right ventricular weight/body weight ratios were 15 and 31%, respectively (data not shown). In summary, chronic coronary artery constriction was associated with biventricular hypertrophy. However, the increase in right ventricular mass exceeded the increase in left ventricular mass.
'25I±CYP binding to myocardial membranes. In a previous study, the specificity of the radioligand for the myocardial p3-adrenoreceptor was established by performing saturation isotherms and competition curves with ,B-adrenoreceptor agonist and antagonists (16) isoproterenol > l-epinephrine > l-norepinephrine > dl-isoproterenol (16). (17) . By employing [32P]NAD as substrate, the labeled components of the membrane can be resolved on SDS polyacrylamide gels and identified by autoradiography. Covalent modification of the a subunit of the stimulatory guanine nucleotide binding protein Gs by cholera toxin inhibits intrinsic GTPase activity, enhancing activation of the catalytic moiety of adenyl cyclase (17) . Therefore, cholera toxin was employed to identify and quantitate the relative amounts of Gs in membranes from hearts of control and experimental rats.
To establish that maximal covalent modification ofGs was present at 60 min, the incorporation of [32P]NAD substrate into myocardial membranes from control and experimental hearts was analyzed at different time intervals up to 120 min (Fig. 3) . The results obtained demonstrated that radiolabeling of membranes was time dependent and maximal at 60 min. Moreover, incorporation of the radioisotope was found to increase linearly with increasing amounts of membrane protein (Fig. 4) .
By employing this approach, quantification of Gs was performed from myocardial membranes ofcontrol and experimental rats (Fig. 5) . As shown in the insert ofFig. 5, the 45-Kd band was labeled in the presence of cholera toxin, but when cholera toxin was omitted no incorporation [32P]NAD was detected. Coronary constriction resulted in a 39% (P < 0.05) and a 54% (P < 0.02) reduction in Gs in the left and right ventricular myocardium, respectively. Whereas similar amounts of Gs were present in the left and right ventricles ofcoronary arterynarrowed animals, a 75% greater content (P < 0.04) was de- tected in the right myocardium with respect to the left in control rats. In summary, chronic coronary artery constriction resulted in a biventricular reduction in the content of the stimulatory guanine nucleotide binding protein. Coronary narrowing abolished the difference in relative amounts of this regulatory protein normally present between the left and right ventricle.
Adenylate cyclase activity. Adenylate cyclase activity was assessed in myocardial membranes by l-isoproterenol stimulated 32P-cyclic AMP generation. In a preliminary study (16) , I-isoproterenol was found to stimulate adenylate cyclase activity in a dose-dependent fashion with maximal stimulation at 100 ,m. Therefore, this dose was employed to compare the activity of this enzyme in the myocardium of sham-operated and coronary-constricted rats. Fig. 6 illustrates that maximal stimulation ofadenylate cyclase in myocardial membranes decreased significantly 5 mo after coronary artery narrowing. In comparison with controls, 84% (P < 0.01) and 45% (P < 0.03) reductions in the generation of cyclic AMP were found in the left and right myocardium of experimental rats, respectively. Moreover, agonist-stimulated adenylate cyclase activity was 45% greater (P < 0.01) in the right ventricle than in the left ventricle of sham-operated animals. Coronary constriction enhanced this difference between the ventricles, resulting in a fivefold greater ability of the right myocardium to generate cyclic AMP in response to l-isoproterenol stimulation. In summary, chronic coronary artery constriction was associated with a marked attenuation of adenylate cyclase activity in the left and right ventricles. The experimental procedure enhanced the difference between the ventricles in agonist stimulated cyclic AMP generation.
Alkaline phosphatase activity. To ensure equivalency of membrane preparations employed in this investigation, the activity of an alternate membrane marker was determined. The activity of alkaline phosphatase was found not to differ in myocardial membranes obtained from ventricles of control and experimental animals: control (n = 3): 447±16 U/ag membrane protein; experimental (n = 4) 449±44 U/,ug membrane protein.
Discussion
Coronary artery constriction and cardiacfunction. Data in the present study demonstrate that cardiac function was markedly depressed 5 mo after moderate degrees of coronary artery constriction. This observation raises the important question of whether magnitudes of coronary stenosis considered to represent clinically insignificant lesions may have to be reevaluated in terms of their potential impact on ventricular dynamics. Moreover, these findings are consistent with previous reports in which abnormalities in ventricular pump function have been found as early as 45 min (5) , and at 3 and 5 d (6) following coronary artery stenosis. In all cases, ventricular performance was impaired, indicating that coronary artery narrowing may lead to sudden alterations ofphysiological parameters that persist during the progression ofthe disease state and long thereafter. The depression in the inotropic ability ofthe myocardium found in this model cannot be attributed only to global or regional myocardial ischemia because resting coronary blood flow is not affected under these conditions (5, 6) . Decreases in basal flow of 10-20% are required to impair regional endocardial function (18) , and nearly complete interruption of resting coronary blood flow must be present before active shortening of the myocardium is completely abolished (18) . Several factors other than coronary perfusion may have participated in the initiation and persistence of diastolic dysfunction and depression in the force generating ability of the myocardium. Changes in myocardial pH and the degree ofbonding between actin and myosin (19) (20) (21) , abnormalities in calcium sequestration by the sarcoplasmic reticulum (19) , and increased myocardial stiffness due to myocyte loss and collagen accumulation (6, 21) may all be involved in the impairment of the mechanical properties of the ventricle (22) (23) (24) .
Coronary artery constriction and cardiac hypertrophy. The current findings indicate that cardiac hypertrophy was present after coronary artery narrowing. However, this tissue response failed to normalize ventricular performance chronically. Although the temporal sequence of events that took place over the 5-mo period of observation was not investigated here, the possibility may be advanced that pathological hypertrophy developed in association with long-term coronary artery constriction. Moreover, the 5-mo interval may represent the phase of transition from decompensated ventricular hypertrophy and myocardial dysfunction to overt failure and death in this animal model.
The observation that the growth adaptation of the right ventricle was greater than the hypertrophic reaction of the left ventricle was unexpected and surprising. Although this difference cannot be explained at present, coronary narrowing leads to myocyte loss in the left myocardium (5, 6) and this phenomenon results in an underestimation ofthe degree ofhypertrophy in the unaffected myocytes (25) (26) (27) (28) (29) (30) , when evaluated on the basis oftissue weight or volume measurements alone. Because the changes in myocyte volume were not determined here, it cannot be excluded that myocyte cellular hypertrophy in the injured left ventricle exceeded that in the right ventricle in spite of a greater increase in right ventricular mass. Recent observations in the aging heart (30), and following acute and healed myocardial infarction (7, 25) favor this possibility.
The functional determinants of cardiac hypertrophy after coronary artery narrowing may be found in the characteristics ofventricular hemodynamics investigated here and in previous studies ofthis animal model (5, 6) . Impairment ofleft ventricular pump performance and chamber dilatation develop immediately after the constriction (5) , resulting in an increase in diastolic and systolic wall stress that may persist chronically, providing a mechanical stimulus for myocyte growth. Moreover, myocytolytic necrosis generates a greater work load on the remaining myocytes, which may increase with time, leading to an additional load-dependent mechanism of myocyte hypertrophy in the left ventricle. The bases ofright ventricular hypertrophy are presently unknown. One possibility is that right ventricular systolic pressure is increased to maintain the pressure gradient across the pulmonary bed in left ventricular failure, or the right ventricle is acting in concert with the injured left ventricle to sustain systemic arterial pressure. Should this be the case, however, the left ventricle would be exposed to a combination of pressure and volume overload stress (5) , whereas the right ventricle would be subjected to pressure overload stress only. (33, 34) and at the onset of myocardial dysfunction (35) typically shows increases in 13-adrenoreceptor density.
The increase in fl-adrenoreceptor antagonist affinity in the hypertrophied right ventricle suggests a fundamental modification in the ligand recognition unit of the receptor. Furthermore, a persistent decrease in ,3-adrenoreceptor antagonist affinity has been reported in a canine model ofpressure overload left ventricular hypertrophy and failure (34, 35) . At the molecular level, alterations in the transcription of the gene for fl-adrenoreceptors may result in the expression ofa modified primary structure of the receptor protein (35) , with a corresponding increase or decrease in receptor antagonist affinity, dependent on the nature of the substitution or deletion.
Differences in fl-adrenoreceptor density and affinity between the left and right myocardium of control hearts were found to be present. The lower number of receptors in the left ventricle with respect to the right may reflect variation in the intensity of postsynaptic adrenergic activity in the two sides of the heart coupled with the hemodynamic characteristics ofthe respective chambers. The left ventricle is faced with a high systemic vascular resistance and consequently operates as a pressure pump. On the other hand, the right ventricle is exposed to the low vascular resistance of the pulmonary circulation and acts as a volume pump (37) . Moreover, the greater mechanical stimulus on the right ventricle during exercise (38) resulted in a down regulation of these receptors and in an increased amount of regulatory protein (37) . All these findings point to the possibility that the altered adrenergic responsiveness of the stressed myocardium can be modulated through postreceptor mechanisms.
The greater quantity of regulatory protein and fl-adrenoreceptors found in the right myocardium under normal conditions supports the notion that the right side ofthe heart may have an enhanced capacity for the transduction ofadrenergic signals to cardiac myocytes.
Coronary artery constriction and adenylate cyclase activity.
The current data indicate that hormone-sensitive adenylate cyclase activity was decreased in the myocardium of coronary artery-narrowed rats. However, the reduced activity of this membrane-bound enzyme was almost twofold greater in the left than in the right ventricle. Thus, cyclic AMP generation was affected more in the failing left ventricle than in the hypertrophic nonfailing right ventricle. This is consistent with the kinetics of fl-adrenoreceptors and regulatory protein interaction that can be inferred from the present results. Whereas both fl-adrenoreceptor density and the quantity of stimulatory guanine nucleotide binding protein were severely depressed in the functionally impaired left ventricle, receptor density was preserved in the right ventricle, maintaining a more favorable stoichiometric relationship between receptors and regulatory protein. On the other hand, the alterations in the fl-adrenoreceptor adenylate cyclase complex found in the hypertrophic right ventricle suggest that impaired transmission of adrenergic signals may occur before ventricular failure supervenes. Furthermore, under normal loading conditions, the molecular components that mediate agonist-stimulated cyclic AMP generation are present in greater quantities in the right than in the left ventricle, strengthening the contention of an enhanced interaction potential between adrenergic influences and effector responses in the right side of the heart. These observations in coronary artery-narrowed animals are in agreement with previous work in experimental models of pressure overload-induced myocardial dysfunction (35, 36) and in the failing human heart (39-41).
In conclusion,-the depression in left ventricular myocardial performance in long-term coronary artery constriction may be mediated by impairment of the transmission of adrenergic signals to myocytes with attenuation oftheir force-generating ability and pump failure. Although extrapolation of results from animals to humans requires considerable caution, the current findings indicate that moderate degrees of coronary artery narrowing may have a significant impact on the molecular events controlling muscle contractile behavior and global cardiac function in the clinical setting.
